HNN3.0

Fondazione Policlinico Universitario Campus Bio-Medico

R&D Institution

www.campusbiomedicohospital.com/the-hospitalRome, Italy
8 profile visits

About

Fondazione Policlinico Universitario Campus Bio-Medico (FPUCBM, https://www.campusbiomedicohospital.com/the-hospital) is a not-for-profit institution pursing the aim of protecting and promoting the human person in the field of healthcare, training, scientific research and innovation in the biomedical and health fields, both clinical and translational. FPUCBM includes 61 departments, 387 beds, 74 outpatient clinics, and 13 operating rooms. It hosts 60+ research units and 10+ labs, producing 700+ scientific publications with a cumulative impact factor of 3500+. Since the foundation of FPUCBM in 2022, 45+ projects have been funded, and over 700+ clinical trials with 8000+ patients are active.

FPUCBM is strongly committed to building and expanding a robust network of partnerships, promoting long-term and practice-oriented collaborations that reinforce the link between biomedical research, healthcare innovation, and the business sector. The Foundation is actively engaged in national and international research initiatives aimed at enhancing healthcare through the systematic introduction and evaluation of innovative digital solutions. It has developed solid expertise in the implementation of pilot programs and clinical studies designed to assess how emerging technologies can be effectively integrated into routine clinical practice, with particular attention to usability, acceptability, and feasibility in real-world care settings.

Representatives

Grant & Knowledge Transfer Office

Fondazione Policlinico Universitario Campus Bio-Medico

Biomedical Engineer

Fondazione Policlinico Universitario Campus Bio-Medico

Full Professor Clinical Pathology and Head of Laboratory Unit

Fondazione Policlinico Universitario Campus Bio-Medico

Marketplace (6)

  • Project cooperation

    Offering expertise in clinical studies

    FPUCBM offers expertise in pilot programs and clinical studies to support integration of emerging technologies into real world care

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-03: Building public trust and outreach in the life sciences
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
    • DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-05: Support for a multilateral initiative on climate change and health research
    • DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-04: Towards climate resilient, prepared and carbon neutral populations and healthcare systems
    • DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-01: Towards a better understanding and anticipation of the impacts of climate change on health
    • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
    • DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)
    Author

    Grant & Knowledge Transfer Office at Fondazione Policlinico Universitario Campus Bio-Medico

    Rome, Italy

  • Project cooperation

    Clinical studies, biomedical and translational research

    Open to EU partnerships for clinical studies, biomedical and translational research, from early development to clinical application.

    Author

    Biomedical Engineer at Fondazione Policlinico Universitario Campus Bio-Medico

    Rome, Italy

  • Project cooperation

    Clinical microbiology and advanced diagnostics for infectious diseases and antimicrobial resistance in Horizon Europe projects

    Expertise in clinical microbiology, molecular diagnostics and antimicrobial resistance to support Horizon Europe collaborative projects.

    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
    Author

    Full Professor Clinical Pathology and Head of Laboratory Unit at Fondazione Policlinico Universitario Campus Bio-Medico

    Rome, Italy

  • Project cooperation

    Advancing Horizon Europe projects through microbiota and metabolomics for translational and clinical research

    Expertise in microbiota and metabolomics to support Horizon Europe projects on host–microbe interactions and translational medicine.

    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
    Author

    Full Professor Clinical Pathology and Head of Laboratory Unit at Fondazione Policlinico Universitario Campus Bio-Medico

    Rome, Italy

  • Project cooperation

    Innovative phage-based antimicrobial therapies to tackle AMR in Horizon Europe projects

    Clinical and translational expertise in bacteriophage-based therapies to address antimicrobial resistance in Horizon Europe consortia.

    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
    Author

    Full Professor Clinical Pathology and Head of Laboratory Unit at Fondazione Policlinico Universitario Campus Bio-Medico

    Rome, Italy

  • Project cooperation

    NGS-based molecular diagnostics for lymphoproliferative diseases in Horizon Europe projects

    Clinical and translational expertise in NGS-based molecular approaches for the diagnosis and stratification of lymphoproliferative diseases.

    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)
    Author

    Full Professor Clinical Pathology and Head of Laboratory Unit at Fondazione Policlinico Universitario Campus Bio-Medico

    Rome, Italy